Rodney W. Lappe

2.3k total citations
51 papers, 1.8k citations indexed

About

Rodney W. Lappe is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Rodney W. Lappe has authored 51 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Cardiology and Cardiovascular Medicine, 20 papers in Physiology and 18 papers in Molecular Biology. Recurrent topics in Rodney W. Lappe's work include Nitric Oxide and Endothelin Effects (18 papers), Renin-Angiotensin System Studies (8 papers) and Heart Failure Treatment and Management (6 papers). Rodney W. Lappe is often cited by papers focused on Nitric Oxide and Endothelin Effects (18 papers), Renin-Angiotensin System Studies (8 papers) and Heart Failure Treatment and Management (6 papers). Rodney W. Lappe collaborates with scholars based in United States, Switzerland and Canada. Rodney W. Lappe's co-authors include Gary Woodnutt, Abhijit Bhat, Hanhua Huang, Robert L. Wendt, Randy L. Webb, Jos F.M. Smits, Jacques Debets, Toshikazu Okada, Michael J. Brody and Dominick DelGrande and has published in prestigious journals such as Journal of Clinical Oncology, Nature reviews. Cancer and Circulation Research.

In The Last Decade

Rodney W. Lappe

48 papers receiving 1.7k citations

Peers

Rodney W. Lappe
Anthony J. Arleth United States
David S. Taylor United Kingdom
L.-C. Tsui Canada
Jerry L. Wessale United States
Kyu Youn Ahn South Korea
Angela Wirth Germany
Anthony J. Arleth United States
Rodney W. Lappe
Citations per year, relative to Rodney W. Lappe Rodney W. Lappe (= 1×) peers Anthony J. Arleth

Countries citing papers authored by Rodney W. Lappe

Since Specialization
Citations

This map shows the geographic impact of Rodney W. Lappe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rodney W. Lappe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rodney W. Lappe more than expected).

Fields of papers citing papers by Rodney W. Lappe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rodney W. Lappe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rodney W. Lappe. The network helps show where Rodney W. Lappe may publish in the future.

Co-authorship network of co-authors of Rodney W. Lappe

This figure shows the co-authorship network connecting the top 25 collaborators of Rodney W. Lappe. A scholar is included among the top collaborators of Rodney W. Lappe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rodney W. Lappe. Rodney W. Lappe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Jie, Tetsuya Ishino, Gang Chen, et al.. (2013). Development of a Novel Long-Acting Antidiabetic FGF21 Mimetic by Targeted Conjugation to a Scaffold Antibody. Journal of Pharmacology and Experimental Therapeutics. 346(2). 270–280. 102 indexed citations
2.
Palanki, Moorthy S. S., Abhijit Bhat, Ben Bolaños, et al.. (2012). Development of a long acting human growth hormone analog suitable for once a week dosing. Bioorganic & Medicinal Chemistry Letters. 23(2). 402–406. 15 indexed citations
3.
Huang, Hanhua, Dingguo Liu, Lingna Li, et al.. (2011). Specifically Targeting Angiopoietin-2 Inhibits Angiogenesis, Tie2-Expressing Monocyte Infiltration, and Tumor Growth. Clinical Cancer Research. 17(5). 1001–1011. 121 indexed citations
4.
Li, Lingna, Hanhua Huang, Venkata Ramana Doppalapudi, et al.. (2011). Antitumor Efficacy of a Thrombospondin 1 Mimetic CovX-Body. Translational Oncology. 4(4). 249–257. 18 indexed citations
5.
Riley, Robert D., Zhi‐Qing Zhao, Vinod H. Thourani, et al.. (2000). Recombinant human complement C5a receptor antagonist reduces infarct size after surgical revascularization. Journal of Thoracic and Cardiovascular Surgery. 120(2). 350–358. 37 indexed citations
6.
Mandiyan, Sreekala, Christoph Schumacher, Catherine L. Cioffi, et al.. (1997). Molecular and Cellular Characterization of Baboon C-Raf as a Target for Antiproliferative Effects of Antisense Oligonucleotides. Antisense and Nucleic Acid Drug Development. 7(6). 539–548. 10 indexed citations
7.
Kwan, Aij‐Lie, Murad Bavbek, A. Y. Jeng, et al.. (1997). Prevention and reversal of cerebral vasospasm by an endothelin-converting enzyme inhibitor, CGS 26303, in an experimental model of subarachnoid hemorrhage. Journal of neurosurgery. 87(2). 281–286. 50 indexed citations
8.
Webb, Randy L., Shiling Hu, Matthew A. Sills, et al.. (1996). In Vitroandin VivoEvaluation of an Endothelin Inhibitor Reveals Novel K+Channel Opening Activity. Biochemical and Biophysical Research Communications. 227(1). 176–181.
9.
Hu, S. L., et al.. (1993). Coupling of Endothelin Receptors to Ion Channels in Rat Glomerular Mesangial Cells. Journal of Cardiovascular Pharmacology. 22(Supplement 8). S149–S153. 11 indexed citations
10.
Rigel, Dean F. & Rodney W. Lappe. (1993). Differential Responsiveness of Conduit and Resistance Coronary Arteries to Endothelin A and B Receptor Stimulation in Anesthetized Dogs. Journal of Cardiovascular Pharmacology. 22(Supplement 8). S243–S247. 34 indexed citations
11.
Lappe, Rodney W., Jeffrey H. Sheldon, & Bryan F. Cox. (1992). Selective Adenosine-2 Agonist Produces Both Direct and Reflex Tachycardia in Normotensive Rats. Journal of Cardiovascular Pharmacology. 19(3). 460–463. 14 indexed citations
12.
Merkel, Linda, et al.. (1992). Demonstration of vasorelaxant activity with an A1-selective adenosine agonist in porcine coronary artery: involvement of potassium channels.. Journal of Pharmacology and Experimental Therapeutics. 260(2). 437–443. 84 indexed citations
13.
Merkel, Linda, Luz María Ruíz‐Godoy Rivera, Mark H. Perrone, & Rodney W. Lappe. (1992). In vitro and in vivo interactions of nitrovasodilators and zaprinast, a cGMP-selective phosphodiesterase inhibitor. European Journal of Pharmacology. 216(1). 29–35. 29 indexed citations
14.
Lappe, Rodney W., et al.. (1992). Pharmacologic Characterization of an EndothelinA (ETA) Receptor Antagonist in Conscious Rats. Journal of Cardiovascular Pharmacology. 20(6). 940–948. 69 indexed citations
15.
Lenz, T., Jean E. Sealey, Rodney W. Lappe, et al.. (1990). Infusion of Recombinant Human Prorenin Into Rhesus Monkeys: Effects on Hemodynamics, Renin-Angiotensin-Aldosterone Axis and Plasma Testosterone. American Journal of Hypertension. 3(4). 257–261. 26 indexed citations
16.
Greenwood, J. M., et al.. (1990). Effects of Atrial Natriuretic Factor in Conscious Rhesus Monkeys With Acute Volume Expansion. American Journal of Hypertension. 3(4). 262–267. 6 indexed citations
17.
Lappe, Rodney W., et al.. (1988). Hypotensive response toatrial natriuretic factor in conscious chronic pulmonary hypertensive rats. European Journal of Pharmacology. 158(1-2). 153–156. 7 indexed citations
18.
Lappe, Rodney W., et al.. (1988). Bronchoprotective and bronchodilator activity of anaritide (human atrial natriuretic factor [102–126]) infusion in the anesthetized guinea pig. Pulmonary Pharmacology. 1(3). 119–123. 6 indexed citations
19.
Lappe, Rodney W., et al.. (1987). Hemodynamic effects of calcitonin gene-related peptide in conscious rats. Regulatory Peptides. 19(5-6). 307–312. 27 indexed citations
20.
Lappe, Rodney W., et al.. (1986). Effects of fenoldopam on regional vascular resistance in conscious spontaneously hypertensive rats.. Journal of Pharmacology and Experimental Therapeutics. 236(1). 187–191. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026